From The Dealing Desk – Aspen (APN) Analysis

Aspen Pharmaceuticals is a share that has gone sideways to lower over the past eighteen months. This share is publishing its results on Thursday 14 September and should give us an indication of the “health” of the share. The expectation is for an increase in headline earnings of between 18% and 22%. The chart is […]